Upgrade

Drugs Made In America Acquisiti

DMIIR

Last
$0.07
Day
+7.7%
1y
-59.4%
5y
-59.4%
52w
-61.8%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.07
EMA 50
0.08
EMA 200
0.11
20d high
-34.2%
5y high
-61.8%
5y range
12th
United States

Positions held

Your positions

DMIIR isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-31
Hold
avoid
Signal
Strong Sell
Target
$0.08
Stop
$0.05
Stop distance
28.6%
Target vs last
+14.3%

Fundamentals

Market cap—Enterprise value—Trailing P/E—Forward P/E—
PEG—Price / book-0.19Beta—Dividend yield—
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE—ROA—Debt / equity—
Current ratio0.34Free cash flow—Analyst recommendationnoneMean target—
52w high$0.0552w low$0.05

Quarterly

No data yet.

Yearly (6y)

No data yet.

Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

No headlines.

DMIIR · daily-13.4% over 13 sessions
Close EMA21 EMA50 EMA200
0.050.060.070.080.102026-092026-092026-092026-092026-092026-102026-10